Akome is a researcher and developer of psychedelic-based pharmaceuticals for the purpose of addressing of rare neurological and mental health disorders with an initial focus on targeting treatments for Alzheimer’s Disease (Alzheimer’s), Parkinson’s Disease (Parkinson’s), Ischemic Stroke (Stroke), and Depression.
Currently, the Company has four (4) provisional patent applications filed with the United States Patent a...
Akome is a researcher and developer of psychedelic-based pharmaceuticals for the purpose of addressing of rare neurological and mental health disorders with an initial focus on targeting treatments for Alzheimer’s Disease (Alzheimer’s), Parkinson’s Disease (Parkinson’s), Ischemic Stroke (Stroke), and Depression.
Currently, the Company has four (4) provisional patent applications filed with the United States Patent and Trademark Office (USPTO).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.